Difference between revisions of "Part:BBa K801075:Design"
(11 intermediate revisions by 4 users not shown) | |||
Line 1: | Line 1: | ||
− | |||
__NOTOC__ | __NOTOC__ | ||
<partinfo>BBa_K801075 short</partinfo> | <partinfo>BBa_K801075 short</partinfo> | ||
Line 5: | Line 4: | ||
<partinfo>BBa_K801075 SequenceAndFeatures</partinfo> | <partinfo>BBa_K801075 SequenceAndFeatures</partinfo> | ||
+ | |||
+ | |||
+ | Composite part of BBa_K801010, BBa_K801072 and BBa_K801012 | ||
+ | <br>'''Keywords:''' | ||
+ | <!--These keywords are necessary to find your part using a fulltext sarch.--> | ||
+ | caffeine, TEF2, expression cassette | ||
+ | |||
+ | <br>'''Abbreviations:''' | ||
+ | <!--*used_abbreviation_1 = full_name_of_used_abbreviations_1--> | ||
+ | <!--*used_abbreviation_2 = full_name_of_used_abbreviations_2--> | ||
+ | * CaDXMT1 = coffea arabica 3,7-dimethylxanthine N-methyltransferase 1 | ||
===Design Notes=== | ===Design Notes=== | ||
− | |||
+ | '''Related BioBrick:''' | ||
+ | [https://parts.igem.org/Part:BBa_K801075 BBa_K801072] | ||
+ | [https://parts.igem.org/Part:BBa_K801077 BBa_K801077] | ||
+ | <!--*Other versions:[https://parts.igem.org/wiki/index.php?title=Part:BBa_?????? BBa_??????: Name_of_part] --> | ||
+ | <!--*Related BioBricks:[https://parts.igem.org/wiki/index.php?title=Part:BBa_?????? BBa_??????: Name_of_part] | ||
+ | '''Cloning details:'''<br> | ||
+ | * Designed in RFC10 | ||
+ | <!--*Designed in RFC10/RFC23/RFC25/RFC25_N-part--> | ||
+ | <!--*Mutation C889G to delete XbaI restriction site--> | ||
+ | <!--*Truncation upstream/downstream compared to template, ?explanation?--> | ||
+ | |||
+ | '''Quality control measures:'''<br> | ||
+ | * Test digest has been performed with Xba1 and Pst1 (see mainpage) | ||
+ | * Part was totally sequenced | ||
+ | <!--*Test digestion using ?enzyme1? & ?enzyme2?/Not yet performed--> | ||
+ | <!--*Sequencing using primer ?primer_name?/Not yet sequenced--> | ||
+ | <!--*Part was partly sequenced/Part was totally sequenced--> | ||
+ | |||
+ | '''Backbone:'''<br> | ||
+ | * Backbone name: pSB1C3' | ||
+ | * Resistance Cp | ||
+ | <!--*Resistance: Amp/Cp/Kan/Tet--> | ||
+ | <!--*Copynumber: low/medium/high--> | ||
+ | |||
+ | '''Protein coding:'''<br> | ||
+ | * CaDXMT1 | ||
+ | <!--*Protein: ?Name_of_gene_product? [Nucleotide 1 to ???]--> | ||
+ | <!--*The protein has the amino acid replacements ???99??? to ???99???.--> | ||
+ | <!--*The protein encoded is posttranslationally modified by ???.--> | ||
+ | <!--*Tag: n-terminally fused/c-terminally fused His5/His6/Strep/Flag/other--> | ||
+ | |||
+ | '''Enzymatic activity:''' | ||
+ | EC-number [http://enzyme.expasy.org/EC/2.1.1.160 2.1.1.160 ] | ||
+ | <!--none/EC-number ?.?.?.?--> | ||
+ | |||
+ | '''Cytotoxicity:'''<br> | ||
+ | This Biobrick is one part of the pathway, which leads to caffeine (the BioBricks BBa_K801073 and BBa_K801074 are further needed). We investigated the toxicity of caffeine and found out, that the growth of yeast strains was inhibited at concentrations of 10 mM. Caffeine with a concentration of 100 mM even showed a lethal effect on yeast cells. Lower concentrations of caffeine (range of micro molar) did not show any growth inhibition or effect. | ||
+ | <!--none/not known/cytotoxic for ''organism name''--> | ||
+ | |||
+ | '''Safety notes:'''<br> | ||
+ | <!--Known and anticipated sefety issues: none/health_risk/environmental_risk/other_risk--> | ||
+ | <!--Known and anticipated security issues: none/other.--> | ||
+ | |||
+ | '''Intellectual property:''' | ||
+ | <!--Information on patent situation.--> | ||
+ | <!--Intellectual property claims made by the authors.--> | ||
+ | |||
+ | '''Corresponding part author/authors:''' | ||
+ | <!--https://igem.org/User_Information.cgi?user_id=????/email--> | ||
===Source=== | ===Source=== | ||
− | + | '''Source:'''<br> | |
+ | * Preexisting BioBrick BBa_K801072 | ||
+ | |||
+ | <!--*Commercial system: plasmid name, system name, company name--> | ||
+ | <!--*Plasmid: p???, provided by ?name_of_person?, ?institute/university?, ?country?--> | ||
+ | <!--*Preexisting BioBrick ?Bba_number?--> | ||
+ | <!--*cDNA Clone: ?clone_name?, ?company_name?--> | ||
+ | <!--*Synthesized by ?company_name?.--> | ||
+ | |||
+ | <!--'''Forward Primer:'''<br><code>5'- ??? - 3'</code><br>--> | ||
+ | <!--'''Reverse Primer:'''<br><code>5'- ??? - 3'</code><br>--> | ||
+ | |||
+ | '''Organism:'''<br> | ||
+ | * Genesequence derived from ''Coffea arabica'' | ||
+ | * codonoptimized for ''Saccharomyces cerevisiae'' | ||
+ | * designed for ''Saccharomyces cerevisiae'' | ||
+ | <!--*Genesequence derived from ''?organism_name?''--> | ||
+ | <!--*Codonoptimized for ''?organism_name?''--> | ||
+ | <!--*Designed for the following Chassis: ''?organism-name?''--> | ||
+ | <!--*Statement about functionality in other chassis.--> | ||
===References=== | ===References=== | ||
+ | <!-- Here you find templates to insert references to literature and different databases--> | ||
+ | |||
+ | '''Literature references:'''<br> | ||
+ | *[http://www.ncbi.nlm.nih.gov/pubmed/12746542 '''Pubmed:''' Uefuji H., Ogita S., Yamaguchi Y., Koizumi N. and Sano H., 2003: Molecular cloning and functional characterization of three distinct n-methyltransferases involved in the caffeine biosynthetic pathway in coffee plants.] | ||
+ | *[http://www.ncbi.nlm.nih.gov/pubmed/16247553 '''Pubmed:''' Uefuji H., Ogita S., Yamaguchi Y., Koizumi N. and Sano H., 2005: Caffeine production in tobacco plants by simultaneous expression of three coffee N-methyltrasferases and its potential as a pest repellant.] | ||
+ | *[http://www.ncbi.nlm.nih.gov/pubmed/16925551 '''Pubmed:''' Kuranda K, Leberre V, Sokol S, Palamarczyk G, François J., 2006: Investigating the caffeine effects in the yeast Saccharomyces cerevisiae brings new insights into the connection between TOR, PKC and Ras/cAMP signalling pathways.] | ||
+ | <!--*[http://www.ncbi.nlm.nih.gov/pubmed/?PMID? '''Pubmed:''' ?Author(s)?, ?year?: ?title?]--> | ||
+ | |||
+ | '''Database references:'''<br> | ||
+ | * NCBI | ||
+ | <!--*[http://www.ncbi.nlm.nih.gov/nuccore/?accessNr? '''GenBank''': ?title?]--> | ||
+ | <!--*[http://www.ebi.ac.uk/interpro/IEntry?ac=?accessNr? '''Interpro''': ?title?]--> | ||
+ | <!--*[http://www.uniprot.org/uniprot/?accessNr? '''Uniprot''': ?title?]--> | ||
+ | <!--*[http://pfam.sanger.ac.uk/family/?accessNr? '''Pfam:''' ?title?]--> | ||
+ | <!--*[http://www.rcsb.org/pdb/explore/explore.do?structureId=?accessNR? '''PDB:''' ?tile?]--> | ||
+ | <!--*[http://www.brenda-enzymes.info/php/result_flat.php4?ecno=?accessNr? '''Branda:''' ?title?]--> |
Latest revision as of 10:31, 24 October 2012
CaDXMT1 expression cassette for yeast
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21INCOMPATIBLE WITH RFC[21]Illegal BglII site found at 1650
Illegal BglII site found at 1746 - 23COMPATIBLE WITH RFC[23]
- 25INCOMPATIBLE WITH RFC[25]Illegal NgoMIV site found at 138
- 1000COMPATIBLE WITH RFC[1000]
Composite part of BBa_K801010, BBa_K801072 and BBa_K801012
Keywords:
caffeine, TEF2, expression cassette
Abbreviations:
- CaDXMT1 = coffea arabica 3,7-dimethylxanthine N-methyltransferase 1
Design Notes
Related BioBrick: BBa_K801072 BBa_K801077
Quality control measures:
- Test digest has been performed with Xba1 and Pst1 (see mainpage)
- Part was totally sequenced
Backbone:
- Backbone name: pSB1C3'
- Resistance Cp
Protein coding:
- CaDXMT1
Enzymatic activity: EC-number [http://enzyme.expasy.org/EC/2.1.1.160 2.1.1.160 ]
Cytotoxicity:
This Biobrick is one part of the pathway, which leads to caffeine (the BioBricks BBa_K801073 and BBa_K801074 are further needed). We investigated the toxicity of caffeine and found out, that the growth of yeast strains was inhibited at concentrations of 10 mM. Caffeine with a concentration of 100 mM even showed a lethal effect on yeast cells. Lower concentrations of caffeine (range of micro molar) did not show any growth inhibition or effect.
Safety notes:
Intellectual property:
Corresponding part author/authors:
Source
Source:
- Preexisting BioBrick BBa_K801072
Organism:
- Genesequence derived from Coffea arabica
- codonoptimized for Saccharomyces cerevisiae
- designed for Saccharomyces cerevisiae
References
Literature references:
- [http://www.ncbi.nlm.nih.gov/pubmed/12746542 Pubmed: Uefuji H., Ogita S., Yamaguchi Y., Koizumi N. and Sano H., 2003: Molecular cloning and functional characterization of three distinct n-methyltransferases involved in the caffeine biosynthetic pathway in coffee plants.]
- [http://www.ncbi.nlm.nih.gov/pubmed/16247553 Pubmed: Uefuji H., Ogita S., Yamaguchi Y., Koizumi N. and Sano H., 2005: Caffeine production in tobacco plants by simultaneous expression of three coffee N-methyltrasferases and its potential as a pest repellant.]
- [http://www.ncbi.nlm.nih.gov/pubmed/16925551 Pubmed: Kuranda K, Leberre V, Sokol S, Palamarczyk G, François J., 2006: Investigating the caffeine effects in the yeast Saccharomyces cerevisiae brings new insights into the connection between TOR, PKC and Ras/cAMP signalling pathways.]
Database references:
- NCBI